Medivir: Directed Issue of SEK140m for MIV-711 - Redeye
Redeye is bullish on Medivir’s directed share issue of SEK140m. It almost doubles the company’s cash position and allows an expanded MIV-711 programme, adding Legg-Calvé-Perthes Disease.
ANNONS
Redeye is bullish on Medivir’s directed share issue of SEK140m. It almost doubles the company’s cash position and allows an expanded MIV-711 programme, adding Legg-Calvé-Perthes Disease.
